• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
  • Member Portal
  • Find a Nephrologist
IgA Nephropathy Foundation Logo
  • IgA Nephropathy Foundation Logo
  • About Us
        • MM About

          • About Us
          • Leadership Team
          • Board of Directors
          • Medical & Scientific Advisory Board
          • IgAN Go Global Network
        • MM About 2

          • Latest News, Media, and Tips
          • Our Partners
          • IgAN Ambassadors
          • Join The Newsletter
  • Events
        • Events

          • Calendar of Events
          • SPARK 2025
          • IgA Nephropathy Day
          • Rare Disease Day
  • Resources
        • MM – Resource 1

          • What is IgAN
          • Diagnosis
          • Understanding Your Lab Results
          • Understanding Your Biopsy
          • Understanding blood pressure and your kidneys
          • Treatment Options
        • MM – Resource 2

          • IgAN Info
          • Faces of IgAN
          • IgAN Risk Quiz
          • AAPI Higher Risk
          • IgAN Cookbook
          • IgAN FAQs
        • MM – Resource 3

          • Support Options
          • Patient Aid
          • IgANCare Program
          • Learn About Insurance
          • Patient + Care Partner Support
          • The IgA Nephropathy Foundation Ambassador Program
          • Caregiver Resources
          • Pregnancy and Family Planning
        • MM – Resource 4

          • Learning & Resources
          • IgAN+ App
          • Tools & Resources
          • Mental Health
          • Podcasts
          • IgAN Nutrition
          • IgAN Recipes
  • Research
        • MM Research

          • IgA Nephropathy Studies
          • IgA Nephropathy Research
          • Published Research Articles
        • MM Research 2

          • Clinical Trials
          • Considering a Clinical Trial?
          • View All Clinical Trials
  • Join
        • MM – Join 1

          • Become a Member
          • The IgA Nephropathy Foundation Ambassador Program
          • Ways to Give
          • Advocacy for IgAN
        • MM – Join 2

          • Join Our Newsletter
          • Patient Registry
  • Donate
  • IgANCare Program

IgA Nephropathy Studies

ENROLL TODAY

The GIGA-kids Study (Genomics of IgA-related disorders in kids Study) is a multi-center collaborative study based at Columbia University and sponsored by the Midwest Pediatric Nephrology Consortium (MWPNC). The study aims to recruit over 1,000 children with IgA nephropathy or Henoch-Schönlein purpura (with or without nephritis) for the purpose of genetic, genomic and biomarker studies.

IgA Nephropathy represents the leading cause of kidney failure among young adults. Henoch-Schönlein purpura is a related disorder with skin manifestations that frequently leads to Nephropathy in children. Our prior genetic studies suggest that patients carrying more risk alleles have an earlier onset of disease. Accordingly, GIGA-kids extends our genetic investigations to pediatric patients, aiming to validate the known disease markers and to discover new genetic and biochemical predictors of disease that may be specific to children.

Please note that they are still accepting new recruitment sites,
and are actively enrolling the following:

  • Pediatric IgA vasculitis cases with and without nephritis
    (biopsy not required)
  • Pediatric IgAN cases (biopsy-diagnosed)
  • Healthy pediatric controls (without active infections,
    autoimmune, or liver disease)

READ THE LATEST GIGA-KIDS NEWSLETTER

Cure Glomerulonephropathy (CureGN) is a multicenter five-year cohort study of glomerular disease patients funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes for Health (NIH) and NephCure Kidney International (NKI).

The CureGN project will study 2,400 children and adults with the following glomerular diseases: minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), and IgA nephropathy (IGAN).

Participants will be followed longitudinally to better understand the causes of disease, response to therapy, and disease progression, with the ultimate objective to cure glomerulonephropathy.

JOIN THE STUDY



Donate
  • Facebook
  • Twitter
  • Instagram
  • YouTube

Quick Links

  • About Us
  • Financials
  • Patient Resources
  • Research
  • Contact Us
  • Join Our Efforts
  • Privacy Policy

Contact Us

(848) 298-4618

PO Box 1322 Wall, NJ 07719

© 2025 All Rights Reserved.

IgAN Foundation Newsletter

Subscribe to our newsletter below!

First Name
Last Name
Enter your email address

No thanks, I’m not interested!

References

  • Hall, Y.N., Fuentes, E.F., Chertow, G.M. et al. Race/ethnicity and disease severity in IgA nephropathy. BMC Nephrol 5, 10 (2004). https://doi.org/10.1186/1471-2369-5-10
  • Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, et al. (2012) Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis. PLoS Genet 8(6): e1002765. doi:10.1371/journal.pgen.1002765